FDA Approves New Indication for Avapritinib : vimarsana.com

Avapritinib (AYVAKIT) is now approved to treat adults with indolent systemic mastocytosis.

Related Keywords

Judith Kain Emmel , Blueprint Medicines Corp , Drug Administration , Mast Cell Disease Society , Kain Emmel , Lysosomal Storage Disease , Systemic Mastocytosis , Mastocytosis , Peripheral Edema , Bedema , Bone Marrow , Platelet Growth Factor , Platelet Derived Growth Factor , Tyrosine Kinase Inhibitor , Rlotinib , Efitinib , Matinib , U11248 , Unitinib , Biologic Therapy , Gist , Gastrointestinal Stromal Tumor , Umor Gastrointestinal Stromal , Boards , Smle , Bones , Dizziness , Hematologic Disorders , I Cell Disease , Ucolipidosis T ,